×
Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression. PDF
$ 40.00
Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression. PDF quantity
$ 40.00
×
A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior PDF
$ 40.00
A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior PDF quantity
$ 40.00
×
Levomilnacipran: More of the Same? PDF
$ 40.00
Levomilnacipran: More of the Same? PDF quantity
$ 40.00
×
Paroxetine in Social Phobia PDF
$ 40.00
Paroxetine in Social Phobia PDF quantity
$ 40.00
×
Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum PDF
$ 40.00
Changes in Antidepressant Metabolism and Dosing Across Pregnancy and Early Postpartum PDF quantity
$ 40.00
×
The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review PDF
$ 40.00
The Role of Non-Pharmaceutical Fentanyl–Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review PDF quantity
$ 40.00
×
Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression PDF
$ 40.00
Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression PDF quantity
$ 40.00
×
Prevalence of Psychiatric Disorders Among Children and Adolescents in Child Welfare Custody Admitted to the Hospital: A Nationwide Inpatient Sample Analysis PDF
$ 40.00
Prevalence of Psychiatric Disorders Among Children and Adolescents in Child Welfare Custody Admitted to the Hospital: A Nationwide Inpatient Sample Analysis PDF quantity
$ 40.00
×
Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine PDF
$ 40.00
Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine PDF quantity
$ 40.00
×
Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study PDF
$ 40.00
Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study PDF quantity
$ 40.00
×
Pharmacotherapy of Paraphilias With Long-Acting Agonists of Luteinizing Hormone-Releasing Hormone: A Systematic Review. PDF
$ 40.00
Pharmacotherapy of Paraphilias With Long-Acting Agonists of Luteinizing Hormone-Releasing Hormone: A Systematic Review. PDF quantity
$ 40.00
×
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder PDF
$ 40.00
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder PDF quantity
$ 40.00
×
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF
$ 40.00
Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart